ライフサイエンスコーパス: immune serum

1 could not be passively transferred with nsP immune serum.

2 lative level of infection in the presence of immune serum.

3 rsed in either strain by passive transfer of immune serum.

4 ot significantly affected by the presence of immune serum.

5 ntially unaltered by the passive transfer of immune serum.

6 complement killing at low concentrations of immune serum.

7 ce could be prevented by passive transfer of immune serum.

8 significantly prolonged by administration of immune serum.

9 ently phagocytosed when opsonized with human immune serum.

10 ls and could be transferred to naive mice by immune serum.

11 resence or absence of heat-inactivated human immune serum.

12 bodies can block the protective potential of immune serum, a potential to which anti-GG antibodies ap

13 ividually) were completely resistant to host immune serum Abs, whereas variants expressing shorter al

14 oelectron microscopy using infection-derived immune serum against T. pallidum indicated that rTromp1

15 eviously showed that the passive transfer of immune serum alone does not confer immunity in the mouse

16 Immune serum also showed an enhanced bactericidal activi

17 Polyclonal reovirus-immune serum also significantly decreased reovirus titer

18 fer studies demonstrated a dominant role for immune serum and a lesser role for immune cells in media

19 vity to cytotoxicity mediated by anti-PAcGM3 immune serum and complement.

20 vector, adsorbed out antibodies to PS/A from immune serum, and elaborated a capsule visualized by imm

21 that there is an apparent synergism between immune serum antibody and immune T cells in achieving pr

22 In this study, we investigated the role of immune serum antibody generated by immunization with a r

23 mmune mice treated with MAbs to PspA or PspA immune serum at 6 and 12 h after infection with 10 times

24 sive transfer of replication-defective virus-immune serum at physiologic concentrations to SCID or B-

25 Further, transfer of immune serum before aerosol challenge had minimal effect

26 IgG2a/c was the major IgG subtype from early immune serum bound by FcgammaRI on the MPhi surface, and

27 be active as disease-resolving components in immune serum but antibody against other antigens may be

28 Administration of Toxoplasma-immune serum, but not nonimmune serum, to vaccinated B-c

29 Passive transfer of immune serum completely protected wild-type, but not Fcg

30 Surprisingly, this immune serum conferred an elevated degree of passive pro

31 Postinfection bovine immune serum contains antibodies that bound to each of t

32 us study showed that opsonization with human immune serum could either promote or antagonize phagocyt

33 production, and supplementation of mice with immune serum could promote basophilia independently of r

34 Furthermore, rNP-immune serum could transfer protection to naive hosts in

35 Although immune serum cross-reacted with the ground cytoplasm of

36 f S. parasanguis FW213 with rabbit anti-FimA immune serum decreased the mean percent adherence (0.34%

37 Passive transfer of immune serum demonstrates the protection is mediated by

38 Transfer of immune serum did not restore resistance in Igh-6(-/-) mi

39 , passive transfer studies suggest that DENV-immune serum does not protect against ZIKV infection.

40 However, Toxoplasma-immune serum effectively inhibits the infection of host

41 Immune serum even mediated protective effects when admin

42 d the enhancement capabilities of Zika virus-immune serum for dengue virus in vitro.

43 Additionally, passive transfer of immune serum from aged vaccinated mice resulted in prote

44 unoblotting using antihistidine antibody and immune serum from an experimentally infected dog.

45 Analyses of immune serum from B10.Q and B10.QbetaBR mice revealed th

46 of either serum from wild-type recipients or immune serum from CCR5-deficient recipients diluted to t

47 fect of Arp antiserum mimics the activity of immune serum from immunocompetent mice when such serum i

48 ts were recapitulated by passive transfer of immune serum from infected immunocompetent mice or T-cel

49 We have previously demonstrated that immune serum from mice infected with B. burgdorferi N40

50 However, although immune serum from T-cell-deficient mice induced disease

51 to neutralization by a longitudinal panel of immune serum from the source infected pony.

52 Passive transfer of immune serum from these mice before challenge protected

53 ion was also achieved by passive transfer of immune serum from whole-parasite-immunized mice.

54 tion, and because passive transfer of IgG in immune serum from wild-type, but not SAP KO mice can pro

55 l of resistance increased with the volume of immune serum given, but the maximum survivable SCHU S4 c

56 insertion mutant library of S Typhimurium to immune serum identified a repertoire of S Typhimurium ge

57 Anti-P48 immune serum immuno-precipitated a mitochondrial protein

58 luated the protective efficacy of polyclonal immune serum in a mouse model of Ebola virus infection.

59 The use of nonhomologous immune serum in animal studies and blood from survivors

60 B. bronchiseptica was, however, killed by immune serum in vitro, and adoptive transfer of anti-Bor

61 f absorbing anti-PlpE antibodies from bovine immune serum, indicating that PlpE is surface exposed in

62 Heat-inactivated immune serum induced passive cutaneous anaphylaxis, sugg

63 IgGs purified from the anti-Ace A immune serum inhibited adherence of 46 degrees C-grown E

64 Previous studies have shown that immune serum is reactive against arthritis-related prote

65 Using DENV-immune serum, it has been shown in vitro that antibody-d

66 Our results suggest that treatment with immune serum limited the sequelae associated with infect

67 Immune serum made against a synthetic peptide with seque

68 e restored by passive transfer of Salmonella-immune serum, may be in part due to a reduced serovar Ty

69 Using anti-MBP-1 immune serum, microaggregate binding to HEp-2 cells was

70 hed susceptibility to both nonimmune and VSV-immune serum neutralization.

71 ontrast to the marked protective efficacy of immune serum on reinfection, the course of primary infec

72 ffect on the inhibitory activity of the host immune serum on susceptible variants.

73 NK cells degranulating against immune serum-opsonized HSV-1-infected fibroblasts had he

74 is by rat AMs of IgG-opsonized erythrocytes, immune serum-opsonized Klebsiella pneumoniae, and IgG-op

75 eficient mice, and passive immunization with immune serum or Ag-specific IgG was sufficient to enable

76 Transfer of immune serum or antibodies obtained from immunocompetent

77 s of extracellular Tat can be neutralized by immune serum or monoclonal antibodies.

78 Prophylactic administration of LVS immune serum or purified immune IgG reduced the severity

79 Functionally, immune serum or the mAb aggregated and induced a fusion-

80 transfer of lymphocytes, passive transfer of immune serum, or passive transfer of DbpA antiserum reve

81 lthough the invasive larvae can be killed by immune serum plus complement, immunity to the cyst stage

82 gle dominant neutralizing epitope, such that immune serum poorly inhibited a variant virus that encod

83 The N-terminal amino acid sequence of the immune serum-precipitable PstB protein was determined, a

84 T. cruzi immune serum prevented CD8(+) T cell functional exhausti

85 ice were dramatically reduced by transfer of immune serum prior to challenge.

86 Opsonization of bacteria with immune serum prior to intraperitoneal infection increase

87 mice can be minimized by treating them with immune serum prior to MHV-1 infection.

88 Finally, GRP78-specific immune serum protected mice with DKA from mucormycosis.

89 challenge while normal serum or Ig-depleted immune serum provided no protection.

90 Col(V) immune serum, purified IgG or B cells from col(V) immune

91 Immune serum, purified IgG, and B cells all induced path

92 ibodies correlated with the avidity of donor immune serum (R, 0.7; P < 0.025), and this relationship

93 antibodies also were abundant in polyclonal immune serum raised against the functionally defective l

94 Polyclonal immune serum raised against the OG1RF-derived recombinan

95 Immune serum raised against the pSAT1-encoded protein re

96 fibronectin was inhibited in the presence of immune serum raised to one truncated fragment of the rep

97 Opsonization with heat-inactivated immune serum reduced the amount of attachment and phagoc

98 . polygyrus challenge, and administration of immune serum restored protective immunity in B cell-defi

99 Immune serum samples from five of nine immunized monkeys

100 Immune serum samples promoted the opsonophagocytic killi

101 populations of DENV-reactive antibodies from immune serum samples to estimate the contribution of ser

102 Immune serum samples were collected from four population

103 MBP-1 immune serum significantly inhibited M. avium subsp. hom

104 was enhanced with anti-F. novicida DeltafopC immune serum, suggesting antibody-dependent cell-mediate

105 n whole fimbriae were used, the antifimbrial immune serum that contained a significant amount of anti

106 ion in killing of P. haemolytica when bovine immune serum that was depleted of anti-PlpE antibodies w

107 une complexes, we found that the transfer of immune serum to B cell-deficient mice could reconstitute

108 Passive transfer of physiologic amounts of immune serum to immunized, B-cell-deficient mice complet

109 ch was consistent with the ability of col(V) immune serum to induce complement-dependent cytotoxicity

110 Passive transfer of immune serum to naive mice prevented virus replication i

111 Transfer of immune serum to SCID mice resulted in 100% survival afte

112 Administration of Toxoplasma-immune serum to ts-4-vaccinated CD4-deficient mice signi

113 It was found that immune serum treatment provided 100% protection against

114 berculosis in the presence of autologous non-immune serum was associated with a 2.5-3-fold increase i

115 The passive transfer of immune serum was not protective.

116 from the lungs and prevent systemic spread, immune serum was passively administered i.p. to naive mi

117 T-cell-deficient mouse immune serum was reactive to decorin binding protein A (

118 and that passive transfer of anti-influenza immune serum was therapeutic in B cell-deficient mice, b

119 e was immunized with these proteins, and the immune serum was used to screen a CEF cDNA expression li

120 infected (immune) mice or in mice receiving immune serum, we observed a significant role for neutrop

121 passively immunized with immune IgM and with immune serum were protected from challenge.

122 When IgGs purified from pools of immune serum were tested at 0.75 mg/ml in the SMFA, all

123 passive transfer of monoclonal Abs (MAbs) or immune serum with a luciferase-expressing Plasmodium yoe

124 Adsorption of immune serum with FimA-positive S. parasanguis FW213 yie

125 molysis was reversed by preincubation of the immune serum with soluble, unconjugated peptide, indicat

126 Adsorption of the immune serum with the loop 5 fusion peptide removed bact